Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongzhuan Chen

Showing results (11-20 of 186) with videos related to

Pageof 19
Sort By:
Neuroscience Letters|May 11, 2016
Activation of the KCa3.1 channel contributes to traumatic scratch injury-induced reactive astrogliosis through the JNK/c-Jun signaling pathwayMengni Yi, Fangfang Dou, Qin Lu, et al.
Bioconjugate Chemistry|March 12, 2019
Harnessing Exosomes for the Development of Brain Drug Delivery SystemsMengna Zheng, Meng Huang, Xinyi Ma, et al.
Journal of Neuroinflammation|November 17, 2018
Ca<sup>2+</sup>-dependent endoplasmic reticulum stress correlation with astrogliosis involves upregulation of KCa3.1 and inhibition of AKT/mTOR signalingZhihua Yu, Fangfang Dou, Yanxia Wang, et al.
Neuroscience Letters|May 8, 2012
The newly identified K+ channel blocker talatisamine attenuates beta-amyloid oligomers induced neurotoxicity in cultured cortical neuronsYanxia Wang, Mingke Song, Lina Hou, et al.
Frontiers in Cellular Neuroscience|October 28, 2017
KCa3.1 Inhibition Switches the Astrocyte Phenotype during Astrogliosis Associated with Ischemic Stroke Via Endoplasmic Reticulum Stress and MAPK Signaling PathwaysZhihua Yu, Mengni Yi, Tianjiao Wei, et al.
Frontiers in Pharmacology|February 4, 2022
TRPV1-Mediated Microglial Autophagy Attenuates Alzheimer's Disease-Associated Pathology and Cognitive DeclineChenfei Wang, Wei Huang, Jia Lu, et al.
Cancer Biology & Therapy|March 18, 2015
Blocking M2 muscarinic receptor signaling inhibits tumor growth and reverses epithelial-mesenchymal transition (EMT) in non-small cell lung cancer (NSCLC)Qingnan Zhao, Xiajing Gu, Chun Zhang, et al.
Frontiers in Oncology|October 5, 2020
Metformin Overcomes Acquired Resistance to EGFR TKIs in EGFR-Mutant Lung Cancer via AMPK/ERK/NF-κB Signaling PathwayLing Li, Tao Wang, Mengdi Hu, et al.
Oncotarget|September 5, 2015
Inactivation of M2 AChR/NF-κB signaling axis reverses epithelial-mesenchymal transition (EMT) and suppresses migration and invasion in non-small cell lung cancer (NSCLC)Qingnan Zhao, Jinnan Yue, Chun Zhang, et al.
Translational Neurodegeneration|October 29, 2024
TRPV1 alleviates APOE4-dependent microglial antigen presentation and T cell infiltration in Alzheimer's diseaseJia Lu, Kexin Wu, Xudong Sha, et al.
Pageof 19

Showing results (11-20 of 186) with videos related to

Sort By:
Pageof 19
Neuroscience Letters|May 11, 2016
Activation of the KCa3.1 channel contributes to traumatic scratch injury-induced reactive astrogliosis through the JNK/c-Jun signaling pathwayMengni Yi, Fangfang Dou, Qin Lu, et al.
Bioconjugate Chemistry|March 12, 2019
Harnessing Exosomes for the Development of Brain Drug Delivery SystemsMengna Zheng, Meng Huang, Xinyi Ma, et al.
Journal of Neuroinflammation|November 17, 2018
Ca<sup>2+</sup>-dependent endoplasmic reticulum stress correlation with astrogliosis involves upregulation of KCa3.1 and inhibition of AKT/mTOR signalingZhihua Yu, Fangfang Dou, Yanxia Wang, et al.
Neuroscience Letters|May 8, 2012
The newly identified K+ channel blocker talatisamine attenuates beta-amyloid oligomers induced neurotoxicity in cultured cortical neuronsYanxia Wang, Mingke Song, Lina Hou, et al.
Frontiers in Cellular Neuroscience|October 28, 2017
KCa3.1 Inhibition Switches the Astrocyte Phenotype during Astrogliosis Associated with Ischemic Stroke Via Endoplasmic Reticulum Stress and MAPK Signaling PathwaysZhihua Yu, Mengni Yi, Tianjiao Wei, et al.
Frontiers in Pharmacology|February 4, 2022
TRPV1-Mediated Microglial Autophagy Attenuates Alzheimer's Disease-Associated Pathology and Cognitive DeclineChenfei Wang, Wei Huang, Jia Lu, et al.
Cancer Biology & Therapy|March 18, 2015
Blocking M2 muscarinic receptor signaling inhibits tumor growth and reverses epithelial-mesenchymal transition (EMT) in non-small cell lung cancer (NSCLC)Qingnan Zhao, Xiajing Gu, Chun Zhang, et al.
Frontiers in Oncology|October 5, 2020
Metformin Overcomes Acquired Resistance to EGFR TKIs in EGFR-Mutant Lung Cancer via AMPK/ERK/NF-κB Signaling PathwayLing Li, Tao Wang, Mengdi Hu, et al.
Oncotarget|September 5, 2015
Inactivation of M2 AChR/NF-κB signaling axis reverses epithelial-mesenchymal transition (EMT) and suppresses migration and invasion in non-small cell lung cancer (NSCLC)Qingnan Zhao, Jinnan Yue, Chun Zhang, et al.
Translational Neurodegeneration|October 29, 2024
TRPV1 alleviates APOE4-dependent microglial antigen presentation and T cell infiltration in Alzheimer's diseaseJia Lu, Kexin Wu, Xudong Sha, et al.
Pageof 19